FTC seeks removal of misleading painkiller ads by top firms
The FTC charges leading nonprescription analgesic ads mislead about therapeutic differences. Firms named include American Home Products Corp and Bristol-Myers Squibb with products Angéa, Anacin, Excedrin, and Bayer with Bayer Aspirin and related brands. The agency seeks corrective ads and disclosure of caffeine or aspirin content. The NAS FDA review finds labeling claims often unsupported. FTC may pursue further action.
MENTIONED IN THIS ARTICLE
American Home Products Corp
Angeia
Arthitis
Bristol Myers Ch
Bullerin
Sterling c
Mekers
Bayer Aspirin
Bayer Children’s Aspirin
Cops
Vardquish
Mido
National Academy of Sciences
Food and Drug Administration
FIC
Bayer
Sterling Drug Co
Sterling
Frank K. Meyers
Bristol Meyers
Also Mentioned on This Page
FTC
Washington
Fdderal Trade Commission
Robert Pilotsky
Bureau of Consumer Protection
Sacramento
Commission
Uets
Cell
NAS
Academy
Bead and Drug Administration
FDA
Federal Trade Commission
Western Union
Charles R. Dooley
Factory
Sleeping Beauty Mattress CO
Vernon, Calif
Master Charge Bank Americard
Dooley’s Hardware Mart
Diamar
Litaire
Long Beach
Banke Awittic
Gene Senegal
Pine Ave
Los Altos Center
Sisarne Ouahe Mall
Lakewood Center
N. Wappen
Hasal
I Caraitos Center
Lence
Fueco
Taylor Caldwell
America
Diane Kennedy Pike
Scott Kennedy
James A. Pike
Diane Fike
Evan Hunter
Gerald Frank
Martin Luther King Jr
Doubleday
Downpan
Long Beard
Santa Ana
Pomona
la Habra
Broiler-Ooyen
Hauswering
Sante Ana
Fomor
la Hobro
Unty Beach
Anny
Bo Raben
Aia
Gerolp
Crestwaaye
Lokewand, Neepert
Minera
Hoppewater
Sanz
Raneag
Lo Habra
Makina
Wiwrort Cohter